3 terminated. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Terminated 3 |
Follow Amyloidosis: new trials by email Literature Review of Amyloidosis trials Research Report on Amyloidosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Characterize Adverse Events Occurring Within One Day of TEGSEDI Administration to Adult Participants With hATTR-PN TEGSEDI - Hereditary Transthyretin Amyloidosis With Polyneuropthy | Phase 4 | Terminated | Akcea Therapeutics | 8 | 2021-01-21 | 2025-04-10 |
| Cardiac Uptake of 18F Florbetapir in Patients Undergoing Chemotherapy F18 Florbetapir (amyvid) cardiac PET/CT imaging - Cardiac Amyloidosis | Phase 4 | Terminated | Medical College of Wisconsin | 4 | 2020-10-01 | 2026-07-16 |
| The Role of F-18 Florbetapir in the Early Detection of Cardiac Amyloidosis F-18 florbetapir - Cardiac Amyloidosis | Phase 4 | Terminated | The Cleveland Clinic | 12 | 2017-01-01 | 2021-07-27 |
Amyloid Neuropathies, Familial (2) · Amyloidosis, Hereditary, Transthyretin-Related (1)
Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3) · Proteostasis Deficiencies (3) · Amyloid Neuropathies (2) · Amyloidosis, Familial (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Heredodegenerative Disorders, Nervous System (2) · Metabolism, Inborn Errors (2) · Nervous System Diseases (2) · Neurodegenerative Diseases (2) · Neuromuscular Diseases (2) · Peripheral Nervous System Diseases (2)
florbetapir (2) · Inotersen (1)
Akcea Therapeutics (1) · Medical College of Wisconsin (1) · The Cleveland Clinic (1)
United States (3) · Canada (1)
Chris Mueller, MD (1) · Steven Nissen, MD (1) · Wael Jaber, MD (1)